|
|
|
|
FDA approves generic Plan B
Source: Drug Topics E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License The Food and Drug Administration recently approved the first generic version of the emergency contraceptive Plan B tablets, 0.75 mg.The generic product...
|
|
|
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN
MORRISTOWN, N.J., June 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.( NYSE:WPI) , a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the...
|
|
|
FDA approves generic Plan B
Drug Topics E-News The Food and Drug Administration recently approved the first generic version of the emergency contraceptive Plan B tablets, 0.75 mg.The generic product will be available by prescription only for women ages 17 and under....
|
|
|
Progestin-containing OC effectiveness not dependent on BMI
MedWire News: The effectiveness of progestin-containing oral contraceptives (OCs) do not decrease with increasing body mass index (BMI), show results from a large prospective active cohort surveillance study.Jrgen Dinger (Center for...
|
|
|
FDA Approves Generic Prescription-Only Version of Plan B Emergency Contraceptive for Women Ages 17 and Under
The U.S.Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17...
|
|
|
US FDA approves generic version of contraceptive Plan B tabs for women ages 17 and under
The US Food and Drug Administration approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg.The generic product will be available by prescription only for women ages 17 and under.
|
|
|
FDA Approves First Generic Version of Emergency Contraceptive Plan B by Watson Laboratories, Inc. (WPI); Presc
MORRISTOWN, N.J., June 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.(NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, , has received approval today from the United States Food and...
|
|
|
Watson Pharmaceuticals Finished At New High For Year Thursday
Watson Pharmaceuticals Inc.(WPI: News ) announced after the bell Wednesday that its subsidiary, Watson Laboratories Inc., received approval from the FDA for levonorgestrel tablets. Levonorgestrel is the generic equivalent to...
|
|
|
Watson Pharmaceuticals Inc granted FDA approval for generic PLAN B
Speciality pharmaceutical company Watson Pharmaceuticals Inc (NYSE: WPI) reported on Wednesday that its subsidiary Watson Laboratories Inc has been granted approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug...
|
|
|
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
MORRISTOWN, N.J., June 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.(NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the...
|
|
|
Watson wins FDA approval for generic contraception drug
(Datamonitor via COMTEX) -- WPI | Quote | Chart | News | PowerRating -- Watson Pharmaceuticals, a specialty pharmaceutical company, has reported that its subsidiary, Watson Laboratories, has received approval from the FDA on its abbreviated...
|
|
|
FDA approves generic version of Plan B
The U.S.Food and Drug Administration has approved the first generic version of emergency contraceptive Plan B (levonorgestrel) tablets. The FDA said the generic product will be available by prescription only for women ages 17 and...
|
|
|
Generic Plan B Pill Approved for Women 17 and Under
The FDA has approved Watson Laboratories ANDA for levonorgestrel 0.75 mg tablets, indicated for the prevention of pregnancy following unprotected intercourse or contraceptive failure.The generic product will be available by...
|
|
|
Watson Pharmaceuticals receives FDA approval for levonorgestrel tablets
Most Popular Links: Pharmacy Jobs | Pharmacy CE | Pharmacy News| Drug Data News| Resources | Computing | Marketplace | Careers | Education | Govt./Legal | PharmacyTech | Business Home| Advertise | Company Info | Contact Us | Free...
|
|
|
Generic Rx-only version of levonorgestrel approved
_ Generic Rx-only version of levonorgestrel approved.
|
|
|
Watson wins FDA approval for generic contraception drug
(Datamonitor via COMTEX) -- Watson Pharmaceuticals, a specialty pharmaceutical company, has reported that its subsidiary, Watson Laboratories, has received approval from the FDA on its abbreviated new drug application for levonorgestrel...
|
|
|
FDA Approves Generic Prescription-Only Version Of Plan B Emergency Contraceptive For Women Ages 17 And Under
The U.S.Food and Drug Administration approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and...
|
|
|
FDA Approves Generic Prescription-Only Version of Plan B Emergency Contraceptive for Women Ages 17 and Under
FDA NEWS RELEASE Media Inquiries: Siobhan DeLancey, 301-796-4668, siobhan.delancey@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA The U.S.Food and Drug Administration today approved the first generic version of the emergency contraceptive...
|
|
|
FDA Approves Generic Prescription-Only Version of Plan B Emergency Contraceptive for Women Ages 17 and Under
-The U.S.Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17...
|
|
|
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
Morristown, NJ/PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.(NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United...
|
|
|
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
MORRISTOWN, N.J., June 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United...
|
|
|
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
% Enter Symbols: Sponsored by: MORRISTOWN, N.J., June 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received...
|
|
|
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
MORRISTOWN, N.J., June 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from...
|
|
|
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
MORRISTOWN, N.J., June 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United...
|
|
|
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
MORRISTOWN, N.J., June 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United...
|
